<bill session="116" type="s" number="1636" updated="2019-09-18T04:59:51Z">
  <state datetime="2019-05-23">REFERRED</state>
  <status>
    <introduced datetime="2019-05-23"/>
  </status>
  <introduced datetime="2019-05-23"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity.</title>
    <title type="short" as="introduced">Ensuring Innovation Act</title>
    <title type="short" as="introduced">Ensuring Innovation Act</title>
    <title type="display">Ensuring Innovation Act</title>
  </titles>
  <sponsor bioguide_id="R000307"/>
  <cosponsors>
    <cosponsor bioguide_id="C001075" joined="2019-05-23"/>
    <cosponsor bioguide_id="S001203" joined="2019-05-23"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-23">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-05-23" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="116" relation="unknown" number="1895"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Chemistry"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
